Ole Andreas Halvorsen
Viking Global Investors
Viking Global Investors 13F holdings
Ole Andreas Halvorsen's Portfolio
- Portfolio value:
- $21.35B≈
- # of securities:
- 66
- Reported for:
- 31 Dec 2019 (Q4)
- Latest filing date:
- 13 Feb 2020
What stocks did Ole Andreas Halvorsen own in 2019 Q4?
What was Ole Andreas Halvorsen's 2019 Q4 portfolio?
Viking Global Investors has disclosed a total of 66 security holdings in their (2019 Q4) SEC 13F filing(s) with portfolio value of $21,350,168,000.
Viking Global Investors's portfolio holdings are tracked quarterly based on SEC 13F filings. Snapshots for each reporting period document the full list of disclosed positions and their portfolio allocations.
Ole Andreas Halvorsen's original 13F reports (2019 Q4) are the official SEC institutional disclosure documents covering all reported equity positions.
66 results
| History | Ticker | Name |
% of portfolio |
Shares* |
Reported price* |
% difference current price* |
Value | Held since* | Held for* |
Security type |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Amazon.com Inc
|
7.70%
|
$92.39
|
+150.97%($231.88)
|
2015 Q2
|
≈ 4.75 years
|
Common Stock
|
-1.64% (-297.24K)
|
||||
|
|
Meta Platforms Inc
|
6.12%
|
$205.25
|
+189.76%($594.72)
|
2016 Q1
|
≈ 4.00 years
|
Common Stock
|
+2.05% (+127.63K)
|
||||
|
|
Adaptive Biotechnologies Corp
|
5.38%
|
$29.92
|
-25.43%($22.31)
|
2019 Q2
|
≈ 0.75 years
|
Common Stock
|
|
||||
|
|
Netflix Inc
|
5.35%
|
$32.36
|
+119.72%($71.10)
|
2015 Q3
|
≈ 4.50 years
|
Common Stock
|
-18.50% (-8.02M)
|
||||
|
|
Uber Technologies Inc
|
5.31%
|
$29.74
|
+127.17%($67.56)
|
2019 Q2
|
≈ 0.75 years
|
Common Stock
|
+162.70% (+23.59M)
|
||||
|
|
BridgeBio Pharma Inc
|
4.37%
|
$35.05
|
+140.60%($84.33)
|
2019 Q2
|
≈ 0.75 years
|
Common Stock
|
|
||||
|
|
Elevance Health Inc
|
4.37%
|
$302.03
|
+25.18%($378.08)
|
2017 Q2
|
≈ 2.75 years
|
Common Stock
|
-20.32% (-787.21K)
|
||||
|
|
Boston Scientific Corp
|
3.92%
|
$45.22
|
+2.03%($46.14)
|
2018 Q3
|
≈ 1.50 years
|
Common Stock
|
+77.53% (+8.08M)
|
||||
|
|
Monster Beverage Corp
|
3.85%
|
$3.97
|
+2,299.00%($95.28)
|
2019 Q2
|
≈ 0.75 years
|
Common Stock
|
+22.88% (+38.57M)
|
||||
|
|
JD.com Inc Adr
|
3.67%
|
$35.23
|
-12.49%($30.83)
|
2019 Q1
|
≈ 1.00 year
|
Depositary Receipt
|
-17.39% (-4.68M)
|
||||
Completely sold out
14 results
| History | Ticker | Name |
Sold shares* |
% change to portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|
|
|
The Boeing Company
|
2019 Q2
|
≈ 0.50 years
|
|||
|
|
RTX Corp
|
2017 Q3
|
≈ 2.25 years
|
|||
|
|
ATHENE HOLDING LTD, CL-A
|
2019 Q2
|
≈ 0.50 years
|
|||
|
|
GRUBHUB INC/OLD
|
2019 Q2
|
≈ 0.50 years
|
|||
|
|
Adobe Systems Incorporated
|
2018 Q4
|
≈ 1.00 year
|
|||
|
|
Alphabet Inc, CL-C
|
2018 Q4
|
≈ 1.00 year
|
|||
|
|
Crown Holdings Inc
|
2019 Q1
|
≈ 0.75 years
|
|||
|
|
Progressive Corp
|
2019 Q3
|
≈ 0.25 years
|
|||
|
|
Sage Therapeutics Inc
|
2019 Q3
|
≈ 0.25 years
|
|||
|
|
Syneos Health Inc
|
2017 Q4
|
≈ 2.00 years
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.